Trimetazidine for stable angina pectoris

Expert Opinion on Pharmacotherapy

Volumn 2, Issue 5, 2001, Pages 857-875

  Cross, H R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cytoprotection; Ischaemia; Metabolism; Stable angina pectoris; Trimetazidine

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCERYL TRINITRATE; ISOSORBIDE DINITRATE; ISOSORBIDE MONONITRATE; METOPROLOL; NICORANDIL; NIFEDIPINE; NITRATE; OXPRENOLOL; PINDOLOL; PLACEBO; PROPRANOLOL; RANOLAZINE; SIMVASTATIN; TEDISAMIL; TRIMETAZIDINE; VERAPAMIL;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; BRADYCARDIA; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DRUG ABSORPTION; DRUG CONTRAINDICATION; DRUG COST; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG STRUCTURE; EXERCISE; FATIGUE; FEMALE; GASTROINTESTINAL SYMPTOM; HEART FUNCTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; MALAISE; MALE; MONOTHERAPY; MUSCLE CRAMP; TACHYCARDIA; TRANSLUMINAL CORONARY ANGIOPLASTY; VERTIGO;

ADRENERGIC BETA-ANTAGONISTS; ANGINA PECTORIS; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANIMALS; CALCIUM CHANNEL BLOCKERS; CORONARY ARTERY BYPASS; EXERCISE TEST; HUMANS; NITROGLYCERIN; TRIMETAZIDINE; VASODILATOR AGENTS; VENTRICULAR FUNCTION, LEFT;

EID: 0034863347     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.2.5.857     Document Type: Article

References (68)

1. Heart and Stroke Statistical Update
2. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on With Chronic Stable Angina)
3. Coronary heart disease: An epidemiological overview
4. Management of stable angina pectoris
5. Seven Countries. A multivariate analysis of death and coronary heart disease
6. Incidence, clinical characteristics and short term prognosis of angina pectoris
7. Coronary heart disease in residents of Rochester, Minnesota V. Prognosis of patients with coronary disease based on initial manifestation
8. Total Ischemic Burden European Trial (TIBET)
9. ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study Infarct Survival) Collaborative Group
10. GISSI-3: Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute nell'infarto Miocardico
11. Role of nitrates in angina pectoris
12. The Beta-Blocker Pooling Project (BBPP): Subgroup findings from randomized trials in post infarction patients
13. Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST)
14. Combination therapy with metoprolol and nifedipine versus monotherapy in patients with stable angina pectoris. Results of the International Multicenter Angina Exercise (IMAGE) Study
15. Treatment of stable angina pectoris with calcium antagonists and beta-blockers. The APSIS study. Angina Prognosis Study in Stockholm
16. Nicorandil. A review of its pharmacology and therapeutic efficacy in angina pectoris
17. Effects of a new metabolic modulator, ranolazine, on exercise tolerance in angina pectoris patients treated with beta-blocker or diltiazem
18. The therapeutic effect of L-carnitine in patients with exercise-induced stable angina: A controlled study
19. D-Ribose as a supplement for cardiac energy metabolism
20. Hemodynamic, antiischemic and neurohumoral effects of tedisamil and atenolol in patients with coronary artery disease
21. The effect of mibefradil on ischemic episodes with and without increase in heart rate
22. Angiotensin converting enzyme inhibition in chronic stable angina: Effects on myocardial ischaemia and comparison with nifedipine
23. Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: A randomized, double-blind, placebo-controlled study
24. Effects of the repeated administration of adenosine and heparin on myocardial perfusion in patients with chronic stable angina pectoris
25. Percutaneous transluminal coronary angioplasty in unstable and stable angina pectoris: A comparison of immediate success and complications
26. A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. Veterans Affairs ACME Investigators
27. Coronary angioplasty versus coronary artery bypass surgery: The Randomized Intervention Treatment of Angina (RITA) trial
28. Coronary bypass surgery in chronic stable angina
29. Effect of coronary artery bypass graft surgery on survival: Overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration
30. Trimetazidine: A cellular anti-ischemic agent
31. Changes in intracellular sodium and pH during ischaemia-reperfusion are attenuated by trimetazidine. Comparison between low- and zero-flow ischaemia
32. Anti-ischemic effects of trimetazidine: 31P-NMR spectroscopy in the isolated rat heart
33. The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase
34. Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions. Potential for pharmacological interventions
35. Is a high glycogen content beneficial or detrimental to the ischemic rat heart? A controversy resolved
36. The role of Na+/K+ ATPase activity during low flow ischemia in preventing myocardial injury: A 31P, 23Na and 87Rb NMR spectroscopic study
37. Role of increased cytosolic free calcium concentration in myocardial ischemic injury
38. Effects of trimetazidine on the calcium transport and oxidative phosphorylation of isolated rat heart mitochondria
39. Ionic and metabolic imbalance as potential factors of ischemia reperfusion injury
40. Effects of trimetazidine on metabolic and functional recovery of postischemic rat hearts
41. Effects of trimetazidine on ischemic contracture in isolated perfused rat hearts
42. Trimetazidine: A novel protective role via maintenance of Na(+)/K(+)-ATPase activity?
43. Effects of trimetazidine on ischemic left ventricular dysfunction in patients with coronary artery disease
44. Acute effects of trimetazidine evaluated by exercise testing
45. Comparison of trimetazidine with nifedipine in effort angina: A double-blind, crossover study
46. Trimetazidine: A new concept in the treatment of angina. Comparison with propranolol in patients with stable angina. Trimetazidine European Multicenter Study Group
47. Effectiveness of trimetazidine in stable effort angina due to chronic coronary insufficiency. A double-blind versus placebo study
48. Effects of trimetazidine on clinical symptoms and tolerance of exercise of patients with syndrome X: A preliminary study
49. Comparison of trimetazidine with atenolol in patients with syndrome X: Effects on diastolic function and exercise tolerance
50. The effects of trimetazidine on ergometric parameters in exercise-induced angina. Controlled multicenter double blind versus placebo study
51. Current concepts in cellular ischemia: Role of trimetazidine
52. Efficacy and tolerance of trimetazidine, a metabolic antianginal, in combination with a hemodynamic antianginal in stable exertion angina. TRIMPOL I, a multicenter study
53. Beneficial effects of trimetazidine in patients with stable angina pectoris under beta-blocker treatment
54. Combination treatment with trimetazidine and diltiazem in stable angina pectoris
55. Therapeutic value of a combination of trimetazidine with a calcium inhibitor in the treatment of chronic coronary insufficiency
56. Antianginal efficacy of the combination of trimetazidine-propranolol compared with isosorbide dinitrate-propranolol in patients with stable angina
57. Trimetazidine and stable angina a double-blind trial
58. Combination therapy of trimetazidine with diltiazem in patients with coronary artery disease. Group of South of France Investigators
59. Chronic effects of myocardial cytoprotector trimetazidine for CAD: Clinical, biochemical and echocardiographic follow-up
60. Trimetazidine effects on exercise tolerance and left ventricular diastolic function in patients with coronary heart disease
61. Clinical trials of beta-blockers in heart failure: A class review
62. Plasma hemostasis and biochemical indices in trimetazidine treatment of patients with chronic heart failure
63. Cardioprotective effect of trimetazidine during coronary artery graft surgery
64. Effects of trimetazidine on heart rate variability and left ventricular systolic performance in patients with coronary artery disease after percutaneous transluminal angioplasty
65. Effects of trimetazidine administration before thrombolysis in patients with anterior myocardial infarction: Short-term and long-term results
66. The effect of trimetazidine on reperfusion arrhythmias in acute myocardial infarction
67. Renoprotective effects of trimetazidine against ischemia-reperfusion injury and cold storage preservation: A preliminary study
68. Trimetazidine ameliorates the hepatic injury associated with ischaemia-reperfusion in rats